Magnus Olof Wijkman (Magnus Wijkman, Magnus O Wijkman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Randomized Controlled Trial

Angiotensin Converting Enzyme

Silver Nanoparticles

Top Venues

Journal of clinical hypertension (Greenwich, Conn.)

European heart journal

Cardiovascular diabetology

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia (2024)
Marcus Vinicius Bolivar Malachias, Magnus Olof Wijkman, Marcello Casaccia Bertoluci
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes. Diabetology & metabolic syndrome 14 (1) (2022)
Jenifer M Brown, Magnus Olof Wijkman, Brian Lee Claggett, Amil M Shah, Christie M Ballantyne, Josef Coresh, Morgan E Grams, Zhiying Wang, Bing Yu, Eric Boerwinkle, Anand Vaidya, Scott D Solomon
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. Hypertension (Dallas, Tex. : 1979) 79 (9) (2022)
Edvin Ström, Carl Johan Östgren, Fredrik H Nystrom, Magnus Olof Wijkman
Associations between fruit consumption and home blood pressure in a randomly selected sample of the general Swedish population. Journal of clinical hypertension (Greenwich, Conn.) 24 (6) (2022)
Klas Sandberg, Marie Kleist, Paul Enthoven, Magnus Olof Wijkman
Hemodynamic responses to In-Bed Cycle Exercise in the acute phase after moderate to severe stroke: A randomized controlled trial. Journal of clinical hypertension (Greenwich, Conn.) 23 (5) (2021)
Magnus Olof Wijkman, Marcus V B Malachias, Brian L Claggett, Susan Cheng, Kunihiro Matsushita, Amil M Shah, Pardeep S Jhund, Josef Coresh, Scott D Solomon, Orly Vardeny
Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study. Journal of clinical hypertension (Greenwich, Conn.) 23 (10) (2021)
Alice M Jackson, Pardeep S Jhund, Inder S Anand, Hans-Dirk Düngen, Carolyn S P Lam, Martin P Lefkowitz, Gerard Linssen, Lars H Lund, Aldo Pietro Maggioni, Marc A Pfeffer, Jean L Rouleau, José Francisco Kerr Saraiva, Michele Senni, Orly Vardeny, Magnus Olof Wijkman, Mehmet Birhan Yilmaz, Yoshihiko Saito, Michael R Zile, Scott D Solomon, John Joseph Valentine McMurray
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European heart journal 42 (36) (2021)
Magnus Olof Wijkman, Brian Claggett, Rafael Diaz, Hertzel C Gerstein, Lars Køber, Eldrin Lewis, Aldo P Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley-Lewis, John J McMurray, Jeffrey Probstfield, Matthew Riddle, Jean-Claude Tardif, Scott D Solomon, Marc A Pfeffer
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial. Cardiovascular diabetology 19 (1) (2020)
Magnus Olof Wijkman
Beta-blockers, hypertension, and stroke outcomes. Journal of clinical hypertension (Greenwich, Conn.) 20 (3) (2018)
Magnus Olof Wijkman, Mary Dena, Sofia Dahlqvist, Sheyda Sofizadeh, Irl Hirsch, Jaakko Tuomilehto, Johan Mårtensson, Ole Torffvit, Henrik Imberg, Aso Saeed, Marcus Lind
Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes. Journal of clinical hypertension (Greenwich, Conn.) 21 (1) (2018)
Magnus Olof Wijkman, Klas Sandberg, Marie Kleist, Lars Falk, Paul Enthoven
The exaggerated blood pressure response to exercise in the sub-acute phase after stroke is not affected by aerobic exercise. Journal of clinical hypertension (Greenwich, Conn.) 20 (1) (2018)